Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Dipeptidyl Peptidase-4 Inhibitors, and Risk of Hospitalization
2012 ◽
Vol 14
(8)
◽
pp. 762-767
◽
2016 ◽
Vol 72
(8)
◽
pp. 1013-1023
◽
2009 ◽
Vol 124
(1)
◽
pp. 113-138
◽